Skip to main content


Generic name: peginesatide (PEG-in-ES-a-tide)
Brand name: Omontys

Clinical studies have shown erythropoietin-stimulating agents (ESAs), such as peginesatide, to increase the risk of serious side effects (eg, blood clots, stroke, heart attack, heart failure) and death in some cases. ESAs have also been shown to shorten the overall survival and/or increase the risk of tumor growth or recurrence in patients with certain types of cancer. Talk with your doctor about the risks and benefits of using peginesatide. Do not use more than the recommended dose without checking with your doctor.

Peginesatide is used for:

Treating anemia in patients with chronic kidney disease who are on dialysis. It may also be used for other conditions as determined by your doctor.

Peginesatide is a synthetic ESA. It works by stimulating the bone marrow to produce more red blood cells.

Do NOT use peginesatide if:

  • you are allergic to any ingredient in peginesatide
  • you have uncontrolled high blood pressure
  • you have chronic kidney disease and you are not on dialysis
  • you have cancer and your anemia is not caused by chronic kidney disease

Contact your doctor or health care provider right away if any of these apply to you.

Before using peginesatide:

Some medical conditions may interact with peginesatide. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

  • if you are pregnant, planning to become pregnant, or are breast-feeding
  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
  • if you have allergies to medicines, foods, or other substances
  • if you have a history of cancer, seizures, blood problems (eg, sickle cell anemia, porphyria, hemolytic anemia, thalassemia), bleeding or clotting problems, stroke, a heart attack or other heart problems (eg, congestive heart failure, ischemic heart disease), or high blood pressure
  • if you have an infection or recent injury; an inflammatory condition (eg, bowel disease, rheumatoid arthritis); or low blood iron, folic acid, or vitamin B12 levels
  • if you have recently had surgery or are scheduled to have surgery
  • if you have recently received another ESA (eg, darbepoetin alfa, epoetin alfa)

Some MEDICINES MAY INTERACT with peginesatide. However, no specific interactions with peginesatide are known at this time. Tell your health care provider if you are taking any other medicines.

Ask your health care provider if peginesatide may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use peginesatide:

Use peginesatide as directed by your doctor. Check the label on the medicine for exact dosing instructions.

  • Peginesatide comes with an extra patient information sheet called a Medication Guide. It also comes with an extra patient leaflet with detailed instructions for use. Read them carefully. Read them again each time you get peginesatide refilled. Ask your doctor, nurse, or pharmacist any questions that you may have about this information.
  • Peginesatide is usually given every month as an injection at your doctor's office, hospital, or clinic. If you will be using peginesatide at home, a health care provider will teach you how to use it. Be sure you understand how to use peginesatide. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.
  • If drawing up a dose into a syringe, be sure to follow the procedure demonstrated to you to prevent contamination of the vial, syringe, or medicine. Never touch the rubber stopper of the vial or the needle of the syringe with your fingers. Always carefully check that you have drawn up the correct dose before administration.
  • Do not dilute peginesatide. Do not mix it with other solutions unless your doctor directs you otherwise.
  • If you are using a single-dose vial, throw away any medicine left in the vial after you have used your dose. Ask your doctor, pharmacist, or other health care provider if you have questions about whether you are using a single-dose vial.
  • If you are using a multiple-use vial, throw away any unused medicine no later than 28 days from the first day that you put a needle into the vial.
  • Peginesatide should be colorless to slightly yellow. Do not use peginesatide if it contains lumps, flakes, or particles, is cloudy or discolored, or if the vial is cracked or damaged.
  • Do not inject peginesatide into an area on your body that is tender, red, bruised, hard, or that has scars or stretch marks.
  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.
  • If you inject more than the prescribed dose of peginesatide, contact your doctor right away.
  • Continue to use peginesatide even if you feel well. Do not miss any doses.
  • If you miss a dose of peginesatide, contact your doctor right away.

Ask your health care provider any questions you may have about how to use peginesatide.

Important safety information:

  • It may take several weeks for peginesatide to work. Do not stop taking peginesatide without checking with your doctor.
  • Do NOT use more than the recommended dose without checking with your doctor.
  • It is important to keep your blood pressure under control while you use peginesatide. Do not stop taking any of your blood pressure medicines without checking with your doctor. Closely follow your doctor's instructions for diet and blood pressure monitoring.
  • Tell your doctor immediately if symptoms of anemia persist or recur, such as unusual tiredness, lack of energy, dizziness, fainting, or pale skin color.
  • Tell your doctor or dentist that you take peginesatide before you receive any medical or dental care, emergency care, or surgery.
  • Lab tests, including blood pressure, iron and hemoglobin levels may be performed while you use peginesatide. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
  • Peginesatide should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.
  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using peginesatide while you are pregnant. It is not known if this medicine is found in breast milk. If you are or will be breast-feeding while you use peginesatide, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of peginesatide:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back pain; diarrhea; headache; joint pain; muscle spasms; nausea; symptoms of upper respiratory tract infection (eg, cough, runny or stuffy nose, sneezing, mild sore throat); vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness; wheezing); calf or leg pain, redness, tenderness, or swelling; chest, jaw, or arm pain; confusion; cool or pale arm or leg; coughing up blood; dizziness or light-headedness; fainting; fever; irregular heartbeat; muscle pain, weakness, or cramping; new or worsening pale skin color, tiredness, or weakness; seizures; severe or persistent headache; shortness of breath; sudden numbness or weakness of the face, arm, or leg, especially on one side of the body; sudden, severe nausea or vomiting; sudden trouble walking, or loss of balance or coordination; sudden, unexplained weight gain; swelling of the hands, ankles, legs, or feet; trouble speaking or understanding others' speech; vision problems.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include severe headache.

Proper storage of peginesatide:

Peginesatide is usually handled and stored by a health care provider. If you are using peginesatide at home, store peginesatide as directed by your pharmacist or health care provider. Keep peginesatide, as well as syringes and needles, out of the reach of children and away from pets.

General information:

  • If you have any questions about peginesatide, please talk with your doctor, pharmacist, or other health care provider.
  • Peginesatide is to be used only by the patient for whom it is prescribed. Do not share it with other people.
  • If your symptoms do not improve or if they become worse, check with your doctor.
  • Check with your pharmacist about how to dispose of unused medicine.

This information should not be used to decide whether or not to take peginesatide or any other medicine. Only your health care provider has the knowledge and training to decide which medicines are right for you. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about peginesatide. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to peginesatide. This information is not specific medical advice and does not replace information you receive from your health care provider. You must talk with your healthcare provider for complete information about the risks and benefits of using peginesatide.

Issue Date: June 3, 2015

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.